Relapsed/refractory patients

Luciano Costa | ASCO 2018 | Phase II study of venetoclax, carfilzomib and dexamethasone in RRMM

L:

ASCO Annual Meeting, 1-5 June 2018, Chicago, IL

Luciano Costa
University of Alabama Comprehensive Cancer Center, Birmingham, US

Interview topic: Luciano Costa | ASCO 2018 | Phase II study of venetoclax, carfilzomib and dexamethasone in RRMM

Download this article:

You can now download this article in Adobe PDF® format.

Download as PDF